p16 gene methylation lacks correlation with angiogenesis and prognosis in multiple myeloma

Cancer Letters

Volumn 222, Issue 2, 2005, Pages 247-254

  Ribas, Christian ^a   Colleoni, Gisele W B ^a   Felix, Roberta Spetic ^a   Regis Silva, Maria Regina ^a   Caballero, Otávia L ^b   Brait, Mariana ^b   Bordin, José Orlando ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

Angiogenesis; Multiple myeloma; p16; Prognosis

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PREDNISONE; PROTEIN P16; VASCULOTROPIN; VINCRISTINE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; FEMALE; GENE FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL; TUMOR CELL;

EID: 18044390654     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.09.038     Document Type: Article

References (34)

1. R. Bataille, and J.L. Harousseau Multiple myeloma N. Engl. J. Med. 336 1997 1657 1664
2. INK4A Exp. Cell Res. 237 1997 7 13
3. M. Gonzalez, M.V. Mateos, R. Garcia-Sanz, A. Balanzategui, R. Lopez-Perez, and M.C. Chillon De novo methylation of tumor suppressor gene p16/INK4A is a frequent finding in multiple myeloma patients at diagnosis Leukemia 14 2000 183 187
4. M.V. Mateos, R. Garcia-Sanz, R. Lopez-Perez, M.J. Moro, E. Ocio, and J. Hernandez Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival Br. J. Haematol. 118 2002 1034 1040
5. T. Tasaka, J. Berenson, R. Vescio, T. Hirama, C.W. Miller, and M. Nagai Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma Br. J. Haematol. 96 1997 98 102
6. S.V. Rajkumar, R.A. Mesa, R. Fonseca, G. Schroeder, M.F. Plevak, and A. Dispenzieri Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis Clin. Cancer Res. 8 2002 2210 2216
7. G. Pruneri, M. Ponzoni, A.J.M. Ferreri, N. Decarli, M. Tresoldi, and F. Raggi Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients Br. J. Haematol. 118 2002 817 820
8. H.F. Dvorak Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J. Clin. Oncol. 20 2002 4368 4380
9. K. Podar, Y.T. Tay, F.E. Davies, S. Lentzsch, M. Sattler, and T. Hideshima Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration Blood 98 2001 428 435
10. H. Harada, K. Nakagawa, S. Iwata, M. Saito, Y. Kumon, and S. Sakaki Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas Cancer Res. 59 1999 3783 3789
11. J. Rak, J.L. Yu, G. Klement, and R.S. Kerbel Oncogenes and angiogenesis: signaling three-dimensional tumor growth J. Investig. Dermatol. Symp. Proc. 5 2000 24 33
12. M. Hallek, P.L. Bergsagel, and K.C. Anderson Multiple myeloma: increasing evidence for a multistep transformation process Blood 91 1998 3 21
13. B.G.M. Durie, and S.E. Salmon Staging and kinetics of multiple myeloma Semin. Oncol. 13 1986 300 309
14. Y.M.D. Lo, I.H.N. Wong, J. Zhang, M.S.C. Tein, M.H.L. Ng, and N.M. Hjelm Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction Cancer Res. 59 1999 3899 3903
15. T. Uchida, T. Kinoshita, T. Ohno, H. Ohashi, H. Nagai, and H. Saito Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia Leukemia 15 2001 157 165
16. INK4b gene methylations in plasma cells from monoclonal gammopathy of undetermined significance Blood 98 2001 244 246
17. J.G. Herman, J.R. Graff, S. Myöhänen, B.D. Nelkin, and S.B. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc. Natl Acad. Sci. USA 93 1996 9821 9826
18. S. Zheng, P. Chen, A. McMillan, A. Lafuente, M.J. Lafuente, and A. Ballesta Correlations of partial and extensive methylation at the p14 (ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors Carcinogenesis 21 2000 2057 2064
19. C.J. Sanguinetti, E. Dias Neto, and A.J. Simpson Rapid silver staining and recovery of PCR products separated on polyacrylamide gels Biotechniques 17 1994 914 921
20. K.S.J. Elenitoba-Johnson, R.D. Gascoyne, M.S. Lim, M. Chhanabai, E.S. Jaffe, and M. Raffeld Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma Blood 91 1998 4677 4685
21. S. Kumar, R. Fonseca, A. Dispenzieri, M.Q. Lacy, J.A. Lust, and L. Wellik Prognostic value of angiogenesis in solitary bone plasmacytoma Blood 101 2003 1715 1717
22. S. Kumar, T.E. Witzig, M.A. Thompson, J. Haug, L. Wellik, and M.M. Timm Expression of angiogenic cytokines by plasma cells: a comparison of MGUS, smoldering myeloma and newly diagnosed symptomatic myeloma Blood 100 2002 807a
23. W.T. Bellamy Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies Semin. Oncol. 28 2001 551 559
24. E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J. Am. Stat. Assoc. 53 1958 457 481
25. M. Urashima, G. Teoh, A. Ogata, D. Chauhan, S.P. Treon, and Y. Sugimoto Characterization of p16INK4A expression in multiple myeloma and plasma cell leukemia Clin. Cancer Res. 3 1997 2173 2179
26. N. Gonzalez-Paz, G. Qu, R. McClure, T. Price-Troska, E. Blood, and S.V. Rajkumar Clinical and biological implications of p16 methylation in multiple myeloma Blood 102 2003 2509a
27. K.I. Mills B.H. Ramsahoye DNA Methylation Protocols 2002 Humana Press New Jersey 78 80
28. M.V. Mateos, M. Gonzalez, A. Balanzategui, R. Lopez-Perez, D. Gonzalez, and M.C. Chillon Status of methylation of p16 gene in multiple myeloma: a comparative study of three methods for its detection Clin. Biochem. 33 2000 415 418
29. L. Holmgren, G. Jacksson, and J. Arbiser p53 induces angiogenesis- restricted dormancy in a mouse fibrosarcoma Oncogene 17 1998 819 824
30. P.P. Claudio, P. Stiegler, C.M. Howard, C. Bellan, C. Minimo, and G.M. Tosi RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo Cancer Res. 61 2001 462 468
31. J.L. Yu, J.W. Rak, B.L. Coomber, D.J. Hicklin, and R.S. Kerbel Effect of p53 status on tumor response to antiangiogenic therapy Science 295 2002 1526 1528
32. K. Nosaka, M. Maeda, S. Tamiya, T. Sakai, H. Mitsuya, and M. Matsuoka Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia Cancer Res. 60 2000 1043 1048
33. M.L. Gonzalgo, T. Hayashida, C.M. Bender, M.M. Pao, Y.C. Tasai, and F.A. Gonzales The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines Cancer Res. 58 1998 1245 1252
34. M. Daskalakis, T.T. Nguyen, C. Nguyen, P. Guldberg, G. Kohler, and P. Wijermans Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment Blood 100 2002 2957 2964